Requirements and special considerations for drug trials with children across six jurisdictions: 2. Ethics review in the regulatory approval process is a research paper published in Frontiers in Medicine (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
FDA HHS
Grant: U18 FD006297
Canadian Institutes of Health Research
Grant: unidentified
unidentified
National Institutes of Health
Grant: 5U18FD006297-04
I-ACT for Children, Global Pediatric Clinical Trials Network
National Institutes of Health
FWCI
1.96
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals